A recent prospective single arm clinical study evaluating RT and anti-CTLA-4 in patients with NSCLC demonstrated safety and in favorably responding patients showed that RT-induced T cell recognition of tumor-specific neo-antigens (19). Here, CTLA4 is linked to neoplasm.